Gilead Sciences, Inc. financial statements
Gilead Sciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 29.44B | 10-K |
| Net income | USD 8.51B | 10-K |
| Cash and equivalents | USD 7.56B | 10-Q |
| Total debt | USD 24.94B | 10-Q |
Gilead Sciences, Inc. financials on 6ix · Gilead Sciences, Inc. on 6ix